Castle Biosciences, Inc. (CSTL)

NGM – Real Time Price. Currency in USD

32.31

+0.07 (0.20%)

Market open: Aug 12, 2026, 12:41 PM EDT

32.24

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 4:15 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

344M

332M

220M

137M

Cost of goods sold

-108M

-73M

-56M

-42M

Gross Profit

236M

259M

164M

95M

Operating expenses (excl. COGS)

-279M

-250M

-232M

-187M

Operating Income

-43M

-68M

-91M

Non-operating income, total

13M

11M

22M

Pretax income

-30M

22M

-57M

-69M

Equity in earnings

Taxes

-3M

-101K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-24M

18M

-57M

-67M

Discontinued operations

Net income

-24M

18M

-57M

-67M

Dilution adjustment

Preferred dividends

Castle Biosciences, Inc. (CSTL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Castle Biosciences, Inc. (CSTL)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Castle Biosciences, Inc. (CSTL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Castle Biosciences, Inc. (CSTL)

Income Statement (Annual)

Income Statement (Annual)